Table 1.
Baseline characteristics of the study population.
Fig 1.
Patient flow through the study.
T2DM type 2 diabetes mellitus, USS ultrasound scan, FIB-4 Fibrosis-4, N number, VTCE vibration-controlled transient elastography, and LSM liver stiffness measure. * lost to follow-up n = 7.
Table 2.
Measures of liver fibrosis in the study sample.
Table 3.
Associations of significant fibrosis of the liver.
Table 4.
Performance of Fib-4 score alone and the new criterion in predicting significant fibrosis.
Fig 2.
Predictive accuracies of algorithms using confusion matrices.
EASL European Association for the Study of the Liver, SF significant fibrosis.